Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
Pulmonx Corp incurred term loan of up to $60.0 million with Perceptive Credit Holdings V, LP at 7.00% plus the greater of one-month term SOFR and 3.75% maturing March 2, 2031.
- Instrument
- term loan
- Principal
- up to $60.0 million
- Counterparty
- Perceptive Credit Holdings V, LP
- Rate
- 7.00% plus the greater of one-month term SOFR and 3.75%
- Maturity
- March 2, 2031
- Event
- incurrence
Exact text from the filing
a senior secured term loan facility in an aggregate principal amount of up to $60.0 million
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Pulmonx Corp issued 1,000,000 shares of warrant to Perceptive Credit Holdings V, LP.
- Security
- warrant
- Shares
- 1,000,000 shares
- Purchaser
- Perceptive Credit Holdings V, LP
Exact text from the filing
On the Closing Date, the Company issued to Perceptive a warrant to purchase up to 1,000,000 shares of the Company’s common stock, par value $0.001 per share, with an exercise price of $1.92 per share
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Pulmonx Corp entered into Credit Agreement and Guaranty with Perceptive Credit Holdings V, LP valued at up to $60.0 million (effective 2026-03-02).
- Action
- entry
- Agreement
- credit facility
- Counterparty
- Perceptive Credit Holdings V, LP
- Value
- up to $60.0 million
- Effective
- 2026-03-02
Exact text from the filing
On March 2, 2026 (the “Closing Date”), Pulmonx Corporation (the “Company”) entered into a Credit Agreement and Guaranty (the “Credit Agreement”) and a Security Agreement (the “Security Agreement”), with Perceptive Credit Holdings V, LP (“Perceptive”), as the initial lender, administrative agent and collateral agent. The Perceptive Credit Agreement provides for a senior secured term loan facility in an aggregate principal amount of up to $60.0 million (the “Loan Facility”).
View on SEC.gov